Table 2 The inhibitory effects of ADHC-AXpn and DHC-Xpn on the viability of human carcinoma cells
ADHC-AXpn (IC50, μM) | DHC-Xpn (IC50, μM) | Dox | |||
|---|---|---|---|---|---|
24 h | 48 h | 24 h | 48 h | 48 h | |
MCF-7 | 30.32 ± 0.79 | 27.81 ± 1.29 | >50 | 42.14 ± 4.63 | 4.07 ± 1.33 |
HepG2 | 40.73 ± 1.46 | 35.65 ± 1.17 | >50 | 42.51 ± 2.57 | 3.80 ± 0.95 |
HepG2/ADM | 33.66 ± 3.64 | 29.61 ± 0.26 | >50 | >50 | 143.47 ± 4.76 |
HeLa | 41.25 ± 0.23 | 35.73 ± 2.15 | >50 | >50 | 4.62 ± 1.37 |
PC3 | >50 | >50 | >50 | >50 | 5.52 ± 1.19 |